Product Information
CARBINOXAMINE ER 4 MG/5 ML SUSP is a generic product labeled by Neos Therapeutics Brands, LLC, priced at $1.0469 per ML under NDC 62542010105. Its NADAC has been published 94 times since Dec 18, 2024.
FDA first approved this application on Mar 28, 2013.
Strength
4 mg/5mL
Manufacturer
Neos Therapeutics Brands, LLCNDC
62542010105
Classification
Generic
Dosage Form
SUSPENSION, EXTENDED RELEASE
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
CARBINOXAMINE MALEATEApproval Type
Authorized Generic (NDA)
FDA Application
NDA022556FDA Approved
3/28/2013
On Market Since
6/1/2024
Pharmacological Classes
Price Statistics
The NADAC for CARBINOXAMINE ER 4 MG/5 ML SUSP has been published 94 times since Dec 18, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.0469 per ML |
|---|---|
| All-time high | $1.0579 (Oct 15, 2025) |
| All-time low | $1.0447 (Mar 19, 2025) |
| 52-week high | $1.0579 |
| 52-week low | $1.0469 |
| Median price | $1.0503 |
| Average price | $1.0508 |
| Largest weekly change | +0.3% (May 21, 2025) |
| Weeks tracked | 94 |
| Tracking since | Dec 18, 2024 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Neos Therapeutics Brands, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Carbinoxamine Maleate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Histamine-1 Receptor Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CARBINOXAMINE ER 4 MG/5 ML SUSP?
The current National Average Drug Acquisition Cost (NADAC) for CARBINOXAMINE ER 4 MG/5 ML SUSP, manufactured by Neos Therapeutics Brands, LLC, is $1.0469 per ML (NDC 62542010105), effective Sep 30, 2026.
How has the price of CARBINOXAMINE ER 4 MG/5 ML SUSP changed over time?
Over the history we have for it, the NADAC for CARBINOXAMINE ER 4 MG/5 ML SUSP has held within roughly two percent of its current level. It has been tracked across 94 weekly CMS publications since Dec 18, 2024.
What are the highest and lowest recorded NADAC prices for CARBINOXAMINE ER 4 MG/5 ML SUSP?
Since Dec 18, 2024, the NADAC for CARBINOXAMINE ER 4 MG/5 ML SUSP has ranged from a low of $1.0447 (Mar 19, 2025) to a high of $1.0579 (Oct 15, 2025), with a median of $1.0503 per ML.
Are there cheaper alternatives to CARBINOXAMINE ER 4 MG/5 ML SUSP?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as CARBINOXAMINE ER 4 MG/5 ML SUSP in a comparable dosage form, but none are currently priced below it.
Who manufactures CARBINOXAMINE ER 4 MG/5 ML SUSP?
CARBINOXAMINE ER 4 MG/5 ML SUSP (NDC 62542010105) is labeled by Neos Therapeutics Brands, LLC, and CMS classifies it as a generic product.